Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R E Champlin

Showing results (41-50 of 255) with videos related to

Pageof 26
Sort By:
Thymus|January 1, 1987
Sustained recovery of hematopoiesis and immunity following transplantation of fetal liver cells in dogsR E Champlin, G Cain, K Stitzel, et al.
Bone Marrow Transplantation|July 1, 1990
Thyroid function tests in patients undergoing bone marrow transplantationJ M Hershman, E Eriksen, N Kaufman, et al.
Current Opinion in Oncology|November 21, 2000
Role of tumor necrosis factor-alpha inhibition with inflixiMAB in cancer therapy and hematopoietic stem cell transplantationD R Couriel, K Hicks, S Giralt, et al.
Bone Marrow Transplantation|September 1, 1993
Intravenous immunoglobulin and CMV-seronegative blood products for prevention of CMV infection and disease in bone marrow transplant recipientsD J Winston, W G Ho, K Bartoni, et al.
Progress in Clinical and Biological Research|January 1, 1990
Effects of recombinant human granulocyte-macrophage colony-stimulating factor as treatment for aplastic anemia and agranulocytosisR E Champlin, S D Nimer, D Oette, et al.
Bone Marrow Transplantation|June 29, 2004
Stem cell transplantation for chronic lymphocytic leukemia: should not more patients get a transplant?E Jabbour, M J Keating, R E Champlin, et al.
Blut|January 1, 1985
Toxicity and bone marrow response of patients with hairy cell leukemia treated with biosynthetic (recombinant) alpha-2-interferonA D Jacobs, F Naiem, R E Champlin, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|July 19, 2002
Risk factors for the development of invasive fungal infections in allogeneic blood and marrow transplant recipientsG R De La Rosa, R E Champlin, D P Kontoyiannis
Clinical Pharmacology and Therapeutics|February 12, 2015
Targeting Bruton's tyrosine kinase with ibrutinib in B-cell malignanciesY Wang, L L Zhang, R E Champlin, et al.
The Journal of Pediatrics|September 1, 1993
Bone marrow transplantation for leukemiaW A Bleyer, R E Champlin, K W Chan, et al.
Pageof 26

Showing results (41-50 of 255) with videos related to

Sort By:
Pageof 26
Thymus|January 1, 1987
Sustained recovery of hematopoiesis and immunity following transplantation of fetal liver cells in dogsR E Champlin, G Cain, K Stitzel, et al.
Bone Marrow Transplantation|July 1, 1990
Thyroid function tests in patients undergoing bone marrow transplantationJ M Hershman, E Eriksen, N Kaufman, et al.
Current Opinion in Oncology|November 21, 2000
Role of tumor necrosis factor-alpha inhibition with inflixiMAB in cancer therapy and hematopoietic stem cell transplantationD R Couriel, K Hicks, S Giralt, et al.
Bone Marrow Transplantation|September 1, 1993
Intravenous immunoglobulin and CMV-seronegative blood products for prevention of CMV infection and disease in bone marrow transplant recipientsD J Winston, W G Ho, K Bartoni, et al.
Progress in Clinical and Biological Research|January 1, 1990
Effects of recombinant human granulocyte-macrophage colony-stimulating factor as treatment for aplastic anemia and agranulocytosisR E Champlin, S D Nimer, D Oette, et al.
Bone Marrow Transplantation|June 29, 2004
Stem cell transplantation for chronic lymphocytic leukemia: should not more patients get a transplant?E Jabbour, M J Keating, R E Champlin, et al.
Blut|January 1, 1985
Toxicity and bone marrow response of patients with hairy cell leukemia treated with biosynthetic (recombinant) alpha-2-interferonA D Jacobs, F Naiem, R E Champlin, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|July 19, 2002
Risk factors for the development of invasive fungal infections in allogeneic blood and marrow transplant recipientsG R De La Rosa, R E Champlin, D P Kontoyiannis
Clinical Pharmacology and Therapeutics|February 12, 2015
Targeting Bruton's tyrosine kinase with ibrutinib in B-cell malignanciesY Wang, L L Zhang, R E Champlin, et al.
The Journal of Pediatrics|September 1, 1993
Bone marrow transplantation for leukemiaW A Bleyer, R E Champlin, K W Chan, et al.
Pageof 26